Skip to Main Content

Author Details

Xiaohong R Yang
National Cancer Institute
2003
134
37
PMIDPaper TitleJournal TitlePublished Year
36260525Gene Expression Profiling Identifies Two Chordoma Subtypes Associated with Distinct Molecular Mechanisms and Clinical Outcomes.Clin Cancer Res2023
36260525Gene Expression Profiling Identifies Two Chordoma Subtypes Associated with Distinct Molecular Mechanisms and Clinical Outcomes.Clin Cancer Res2023
37585199Estimated Prevalence, Tumor Spectrum, and Neurofibromatosis Type 1-Like Phenotype of CDKN2A-Related Melanoma-Astrocytoma Syndrome.JAMA Dermatol2023
37213281Editorial: Chordoma: advances in biology and clinical management.Front Oncol2023
36707629FANCM missense variants and breast cancer risk: a case-control association study of 75,156 European women.Eur J Hum Genet2023
37010652Tumour Infiltrating Lymphocytes (TILs) and immune composition in breast cancer patients from Kenya: Spatial distributions and associations with risk factors and tumour characteristics.Breast Cancer Res Treat2023
36876055Association of germline variants in telomere maintenance genes (<i>POT1, TERF2IP, ACD,</i> and <i>TERT</i>) with spitzoid morphology in familial melanoma: A multi-center case series.JAAD Int2023
37451831Evaluation of European-based polygenic risk score for breast cancer in Ashkenazi Jewish women in Israel.J Med Genet2023
37444426Spectrum and Frequency of Germline <i>FANCM</i> Protein-Truncating Variants in 44,803 European Female Breast Cancer Cases.Cancers (Basel)2023
36991516DNA methylation age in paired tumor and adjacent normal breast tissue in Chinese women with breast cancer.Clin Epigenetics2023
37585199Estimated Prevalence, Tumor Spectrum, and Neurofibromatosis Type 1-Like Phenotype of CDKN2A-Related Melanoma-Astrocytoma Syndrome.JAMA Dermatol2023
36991516DNA methylation age in paired tumor and adjacent normal breast tissue in Chinese women with breast cancer.Clin Epigenetics2023
37451831Evaluation of European-based polygenic risk score for breast cancer in Ashkenazi Jewish women in Israel.J Med Genet2023
37213281Editorial: Chordoma: advances in biology and clinical management.Front Oncol2023
37444426Spectrum and Frequency of Germline <i>FANCM</i> Protein-Truncating Variants in 44,803 European Female Breast Cancer Cases.Cancers (Basel)2023
37010652Tumour Infiltrating Lymphocytes (TILs) and immune composition in breast cancer patients from Kenya: Spatial distributions and associations with risk factors and tumour characteristics.Breast Cancer Res Treat2023
36876055Association of germline variants in telomere maintenance genes (<i>POT1, TERF2IP, ACD,</i> and <i>TERT</i>) with spitzoid morphology in familial melanoma: A multi-center case series.JAAD Int2023
36707629FANCM missense variants and breast cancer risk: a case-control association study of 75,156 European women.Eur J Hum Genet2023
34906508Novel loss-of-function variant in DENND5A impedes melanosomal cargo transport and predisposes to familial cutaneous melanoma.Genet Med2022
35585550Breast cancer risks associated with missense variants in breast cancer susceptibility genes.Genome Med2022
35762214Rare germline variants in PALB2 and BRCA2 in familial and sporadic chordoma.Hum Mutat2022
35377867SUITOR: Selecting the number of mutational signatures through cross-validation.PLoS Comput Biol2022
36269225Impact of Transcript (p16/p14ARF) Alteration on Cancer Risk in CDKN2A Germline Pathogenic Variant Carriers.JNCI Cancer Spectr2022
35723569Distinct Reproductive Risk Profiles for Intrinsic-Like Breast Cancer Subtypes: Pooled Analysis of Population-Based Studies.J Natl Cancer Inst2022
36409970Gene-Level Associations in Patients With and Without Pathogenic Germline Variants in <i>CDKN2A</i> and Pancreatic Cancer.JCO Precis Oncol2022
35717579Rare germline deleterious variants increase susceptibility for lung cancer.Hum Mol Genet2022
35333343Association of Genetic Ancestry With Terminal Duct Lobular Unit Involution Among Healthy Women.J Natl Cancer Inst2022
35042965Rare germline copy number variants (CNVs) and breast cancer risk.Commun Biol2022
34906508Novel loss-of-function variant in DENND5A impedes melanosomal cargo transport and predisposes to familial cutaneous melanoma.Genet Med2022
35181301Integrated Analysis of Coexpression and Exome Sequencing to Prioritize Susceptibility Genes for Familial Cutaneous Melanoma.J Invest Dermatol2022
35585550Breast cancer risks associated with missense variants in breast cancer susceptibility genes.Genome Med2022
35377867SUITOR: Selecting the number of mutational signatures through cross-validation.PLoS Comput Biol2022
35762214Rare germline variants in PALB2 and BRCA2 in familial and sporadic chordoma.Hum Mutat2022
35723569Distinct Reproductive Risk Profiles for Intrinsic-Like Breast Cancer Subtypes: Pooled Analysis of Population-Based Studies.J Natl Cancer Inst2022
35717579Rare germline deleterious variants increase susceptibility for lung cancer.Hum Mol Genet2022
36409970Gene-Level Associations in Patients With and Without Pathogenic Germline Variants in <i>CDKN2A</i> and Pancreatic Cancer.JCO Precis Oncol2022
36269225Impact of Transcript (p16/p14ARF) Alteration on Cancer Risk in CDKN2A Germline Pathogenic Variant Carriers.JNCI Cancer Spectr2022
35042965Rare germline copy number variants (CNVs) and breast cancer risk.Commun Biol2022
35181301Integrated Analysis of Coexpression and Exome Sequencing to Prioritize Susceptibility Genes for Familial Cutaneous Melanoma.J Invest Dermatol2022
35333343Association of Genetic Ancestry With Terminal Duct Lobular Unit Involution Among Healthy Women.J Natl Cancer Inst2022
32359158Combined Associations of a Polygenic Risk Score and Classical Risk Factors With Breast Cancer Risk.J Natl Cancer Inst2021
32359158Combined Associations of a Polygenic Risk Score and Classical Risk Factors With Breast Cancer Risk.J Natl Cancer Inst2021
33811164The Impact of Longitudinal Surveillance on Tumor Thickness for Melanoma-Prone Families with and without Pathogenic Germline Variants of <i>CDKN2A</i> and <i>CDK4</i>.Cancer Epidemiol Biomarkers Prev2021
34174935Breast cancer risk factors in relation to molecular subtypes in breast cancer patients from Kenya.Breast Cancer Res2021
34070849Rare Germline Variants in Chordoma-Related Genes and Chordoma Susceptibility.Cancers (Basel)2021
33536423Whole genome sequencing of skull-base chordoma reveals genomic alterations associated with recurrence and chordoma-specific survival.Nat Commun2021
33471991Breast Cancer Risk Genes - Association Analysis in More than 113,000 Women.N Engl J Med2021
33952648Tumor-Associated Stromal Cellular Density as a Predictor of Recurrence and Mortality in Breast Cancer: Results from Ethnically Diverse Study Populations.Cancer Epidemiol Biomarkers Prev2021
33990587Author Correction: A case-only study to identify genetic modifiers of breast cancer risk for BRCA1/BRCA2 mutation carriers.Nat Commun2021
33500318Breast Cancer Risk Factors and Survival by Tumor Subtype: Pooled Analyses from the Breast Cancer Association Consortium.Cancer Epidemiol Biomarkers Prev2021
  • 1 - 50 of 268

Recommended Authors

Fred Hutchison Cancer Center
Career Start Year 2015
Number of shared co-authors 7
Netherlands Cancer Institute
Career Start Year 2012
Number of shared co-authors 21
Indiana University School of Medicine
Career Start Year 2011
Number of shared co-authors 0
The Ohio State University
Career Start Year 2007
Number of shared co-authors 94
University of California san francisco
Career Start Year 2007
Number of shared co-authors 4
University of California San Francisco.
Career Start Year 2007
Number of shared co-authors 5
QIMR Berghofer Medical Research Institute
Career Start Year 2006
Number of shared co-authors 22
QIMR Berghofer Medical Research Institute
Career Start Year 2006
Number of shared co-authors 37
Population Health Sciences Institute, Newcastle University
Career Start Year 2004
Number of shared co-authors 9
Mayo Clinic
Career Start Year 2004
Number of shared co-authors 66
Clinical Investigations Branch, National Cancer Institute
Career Start Year 2004
Number of shared co-authors 23
University of California
Career Start Year 2003
Number of shared co-authors 4
H. Lee Moffitt Cancer Center and Research Institute
Career Start Year 2003
Number of shared co-authors 116
Fox Chase Cancer Center
Career Start Year 2002
Number of shared co-authors 1
The First Hospital of Lanzhou University
Career Start Year 2002
Number of shared co-authors 3
Center for Cancer Research, National Cancer Institute
Career Start Year 2002
Number of shared co-authors 14
Olivia Newton-John Cancer Research Institute
Career Start Year 2002
Number of shared co-authors 1
Lineberger Cancer Center, University of North Carolina
Career Start Year 2002
Number of shared co-authors 19
Familial Cancer Clinic, Hospital Sant Pau
Career Start Year 2000
Number of shared co-authors 55
AC Camargo Cancer Center
Career Start Year 1998
Number of shared co-authors 9
University of Oslo
Career Start Year 1997
Number of shared co-authors 9
Center for Cancer Research, National Cancer Institute
Career Start Year 1995
Number of shared co-authors 28
Novartis Pharmaceuticals
Career Start Year 1995
Number of shared co-authors 3
The Institute for Clinical and Translational Research, Baylor College of Medicine
Career Start Year 1995
Number of shared co-authors 16
University Health Network
Career Start Year 1994
Number of shared co-authors 2
12224University of California san francisco
Career Start Year 1993
Number of shared co-authors 6
Center for Cancer Equity and Engagement, Dana-Farber/Harvard Cancer Center
Career Start Year 1991
Number of shared co-authors 102
School of Clinical Medicine, University of NSW Sydney, Lowy Cancer Research Centre
Career Start Year 1991
Number of shared co-authors 115
The University of Texas MD Anderson Cancer Center
Career Start Year 1991
Number of shared co-authors 32
Fred Hutchinson Cancer Research Center
Career Start Year 1991
Number of shared co-authors 9

Collaborators

National Cancer Institute, National Institutes of Health
Co-authored papers 41
National Cancer Institute
Co-authored papers 41
National Cancer Institute
Co-authored papers 39
The Usher Institute, The University of Edinburgh
Co-authored papers 34
National Cancer Institute.
Co-authored papers 30
Mayo Clinic
Co-authored papers 28
The M. Sklodowska-Curie Cancer Center and Institute of Oncology
Co-authored papers 26
Center for Cancer Genetic Epidemiology, University of Cambridge
Co-authored papers 22
University of Cambridge
Co-authored papers 21
German Cancer Research Center (DKFZ)
Co-authored papers 20
Co-authored papers 20
National Cancer Institute
Co-authored papers 20
Frederick National Laboratory for Cancer Research
Co-authored papers 19
National Cancer Institute
Co-authored papers 19
Co-authored papers 19
Co-authored papers 18
Frederick National Laboratory for Cancer Research
Co-authored papers 18
Otto-Friedrich-University Bamberg
Co-authored papers 17
Co-authored papers 17
Co-authored papers 17
University of Toronto
Co-authored papers 17
University of Southern California
Co-authored papers 16
Co-authored papers 16
Mayo Clinic
Co-authored papers 15
Harvard T. H. Chan School of Public Health
Co-authored papers 15
Co-authored papers 14
Pomeranian Medical University
Co-authored papers 14
QIMR Berghofer Medical Research Institute
Co-authored papers 14
Faculty of Clinical Medicine, University of Oslo
Co-authored papers 14
Instituto de Salud Carlos III
Co-authored papers 13